Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 61 to 75 of 731 results for objectives

  1. Using mindfulness to support mental wellbeing at work for children's social care front line practitioners

    Yes Example Aims and objectives Reasons for

    Shared learning
    Last updated
    2 December 2020

  2. Implementing transition care locally and nationally using the 'Ready Steady Go' programme

    Yes Example Aims and objectives Reasons for

    Shared learning
    Last updated
    27 January 2017

  3. EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer (DG9)

    Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic

    Diagnostics guidance
    Published
    14 August 2013
    View recommendations

    Sections for DG9

  4. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes (NG5)

    This guideline covers safe and effective use of medicines in health and social care for people taking 1 or more medicines. It aims to ensure that medicines provide the greatest possible benefit to people by encouraging medicines reconciliation, medication review, and the use of patient decision aids.

    NICE guideline
    Published
    4 March 2015
    View recommendations

    Sections for NG5

  5. Development of a Best Interest Decision Making Toolkit to support health and care professionals who work with those with cognitive impairment to achieve better outcomes

    Yes Example Aims and objectives Reasons for

    Shared learning
    Last updated
    1 February 2021

  6. A Community of Practice for Non-medical Prescribing Leads

    Yes Example Aims and objectives Reasons for

    Shared learning
    Published
    31 May 2019

  7. Wigan Council's Affordable Warmth Access Referral Mechanism (AWARM) – the original single-point-of-contact health and housing referral service for people living in cold homes

    Yes Example Aims and objectives Reasons for

    Shared learning
    Last updated
    26 June 2017

  8. Driving quality through the implementation of NICE guidance in a local authority

    No Example Aims and objectives Reasons for

    Shared learning
    Published
    6 November 2018

  9. NICE visualisation of treatment options incorporating technology appraisals: interim process guide (PMG38)

    NICE visualisation of treatment options incorporating technology appraisals: interim process guide

  10. Using Nutrition Support NICE Quality Standards as a basis to improve management of malnourished care home residents with a Food First approach

    Yes Example Aims and objectives Reasons for

    Shared learning
    Last updated
    27 June 2018

  11. QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) (MIB318)

    NICE has developed a medtech innovation briefing (MIB) on QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) .

    Medtech innovation briefing
    Published
    7 March 2023

  12. Public board meeting agenda and papers: November 2020

    Agenda and papers of the NICE public board meeting on 18 November 2020

  13. Upadacitinib for treating active non-radiographic axial spondyloarthritis (TA861)

    Evidence-based recommendations on upadacitinib (Rinvoq) for treating active non-radiographic axial spondyloarthritis in adults.

    Technology appraisal guidance
    Published
    1 February 2023
    View recommendations

    Sections for TA861

  14. Implementing the Workplace Wellbeing Charter in 3 small businesses in Bath and North East Somerset (B&NES) in 2014-15

    Yes Example Aims and objectives Reasons for

    Shared learning
    Last updated
    11 September 2015

  15. Golimumab for treating non-radiographic axial spondyloarthritis (TA497)

    Evidence-based recommendations on golimumab (Simponi) for severe non-radiographic axial spondyloarthritis. This drug is for adults who have tried nonsteroidal anti-inflammatory drugs (NSAIDs), but they have not worked.

    Technology appraisal guidance
    Published
    10 January 2018
    View recommendations

    Sections for TA497